Editor’s Note: The following is testimony delivered by Darius Lakdawalla to the U.S. House Committee on Oversight and Government Reform’s Subcommittee on Economic Growth, Energy Policy, and Regulatory Affairs and the Subcommittee on Health Care and Financial Service on Dec. 10, 2025. More information about the hearing can be found here.
Key Points
- Rational and forward-thinking regulatory reforms can stimulate the uptake of new technologies that make good health more accessible and affordable.
- CMS has an opportunity to reform and focus Medicare’s coverage with evidence development (CED) program to better achieve its goals of generating evidence while ensuring new technologies are covered.
- Medicare Advantage can be transformed into a laboratory for forward-thinking reforms that stimulate valuable investments in prevention by aligning payers’, innovators’, and patients’ interests, serving as a model for the commercial insurance market.
- Finally, there is opportunity for prudent regulatory reform in healthcare price transparency that best serves the needs of today’s patients and the generations of patients to come.
Full testimony is available here.
